NO983356D0 - Nye 19-nor-pregnenderivater - Google Patents

Nye 19-nor-pregnenderivater

Info

Publication number: NO983356D0
Authority: NO; Norway
Prior art keywords: new; derivative derivatives; derivative; derivatives
Prior art date: 1996-01-22

Application number

NO983356A

Other languages

English (en)

Other versions

NO983356L (no

NO309572B1 (no

Inventor

Alain Piasco

Jean Lafay

Rumi Delansorne

Jacques Paris

Jean Claude-Pascal

Original Assignee

Theramex

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-22

Filing date

1998-07-21

Publication date

1998-07-21

1998-07-21 Application filed by Theramex filed Critical Theramex

1998-07-21 Publication of NO983356L publication Critical patent/NO983356L/no

1998-07-21 Publication of NO983356D0 publication Critical patent/NO983356D0/no

2001-02-19 Publication of NO309572B1 publication Critical patent/NO309572B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO983356A 1996-01-22 1998-07-21 Nye 19-nor-pregnen-derivater NO309572B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96400146A EP0785212A1 (en)	1996-01-22	1996-01-22	New 19-nor-pregnene derivatives
PCT/EP1997/000357 WO1997027210A1 (en)	1996-01-22	1997-01-17	New 19-nor-pregnene derivatives

Publications (3)

Publication Number	Publication Date
NO983356L NO983356L (no)	1998-07-21
NO983356D0 true NO983356D0 (no)	1998-07-21
NO309572B1 NO309572B1 (no)	2001-02-19

Family

ID=8225217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983356A NO309572B1 (no)	1996-01-22	1998-07-21	Nye 19-nor-pregnen-derivater

Country Status (36)

Country	Link
US (1)	US6180803B1 (no)
EP (2)	EP0785212A1 (no)
JP (2)	JP4368945B2 (no)
KR (1)	KR100396902B1 (no)
CN (1)	CN1187366C (no)
AP (1)	AP1176A (no)
AR (1)	AR005500A1 (no)
AT (1)	ATE184015T1 (no)
BR (1)	BR9707064A (no)
CA (1)	CA2243504C (no)
CO (1)	CO4810230A1 (no)
CZ (1)	CZ292047B6 (no)
DE (1)	DE69700470T2 (no)
DZ (1)	DZ2169A1 (no)
EE (1)	EE03692B1 (no)
ES (1)	ES2140961T3 (no)
GR (1)	GR3031954T3 (no)
HK (1)	HK1018216A1 (no)
HU (1)	HU221796B1 (no)
ID (1)	ID15840A (no)
IL (1)	IL125379A (no)
IS (1)	IS1902B (no)
JO (1)	JO1971B1 (no)
MY (1)	MY116845A (no)
NO (1)	NO309572B1 (no)
NZ (1)	NZ330954A (no)
OA (1)	OA10813A (no)
PE (1)	PE55998A1 (no)
PL (1)	PL185608B1 (no)
RU (1)	RU2166509C2 (no)
SI (1)	SI0886645T1 (no)
TN (1)	TNSN97015A1 (no)
TR (1)	TR199801399T2 (no)
TW (1)	TW411345B (no)
WO (1)	WO1997027210A1 (no)
ZA (1)	ZA97521B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2776191B1 (fr) *	1998-03-23	2002-05-31	Theramex	Composition hormonale topique a effet systemique
TWI290549B (en) *	2000-06-02	2007-12-01	Astrazeneca Ab	Process for the preparation of cyclopropyl carboxylic acid ester and derivatives
US20070225379A1 (en) *	2001-08-03	2007-09-27	Carrara Dario Norberto R	Transdermal delivery of systemically active central nervous system drugs
ES2283425T3 (es)	2000-08-03	2007-11-01	Antares Pharma Ipl Ag	Nueva composicion para la administracion transdermica y/o transmucosa de compuestos activos que asegura niveles terapeutiocos adecuados.
US8980290B2 (en)	2000-08-03	2015-03-17	Antares Pharma Ipl Ag	Transdermal compositions for anticholinergic agents
US20040198706A1 (en) *	2003-03-11	2004-10-07	Carrara Dario Norberto R.	Methods and formulations for transdermal or transmucosal application of active agents
US7198801B2 (en)	2000-08-03	2007-04-03	Antares Pharma Ipl Ag	Formulations for transdermal or transmucosal application
FR2814074B1 (fr) *	2000-09-15	2003-03-07	Theramex	Nouvelles compositions estro-progestatives topiques a effet systemique
HUE025239T2 (en)	2003-09-03	2016-03-29	Miscon Trading S A	Methods for treating endometriosis
MXPA06003316A (es) *	2003-10-10	2006-06-08	Antares Pharma Ipl Ag	Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
US7425340B2 (en)	2004-05-07	2008-09-16	Antares Pharma Ipl Ag	Permeation enhancing compositions for anticholinergic agents
WO2007124250A2 (en)	2006-04-21	2007-11-01	Antares Pharma Ipl Ag	Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en)	2005-05-27	2006-11-30	Antares Pharma Ipl Ag	Methods and apparatus for transdermal or transmucosal application of testosterone
WO2008067991A2 (en) *	2006-12-08	2008-06-12	Antares Pharma Ipl Ag	Skin-friendly drug complexes for transdermal administration
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
EP2782584B1 (en)	2011-11-23	2021-06-09	TherapeuticsMD, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es)	2014-05-22	2016-10-12	Therapeuticsmd Inc	Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US9173915B1 (en) *	2014-10-10	2015-11-03	Peter F. Kador	Antioxidant eye drops
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
CN109364020B (zh) *	2015-09-02	2021-12-28	盛世泰科生物医药技术(苏州)有限公司	一种用于预防和治疗白内障的眼用制剂及其制备方法
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
KR20180126582A (ko)	2016-04-01	2018-11-27	쎄러퓨틱스엠디, 인코퍼레이티드	스테로이드 호르몬 약제학적 조성물
CN110452279B (zh) *	2019-05-13	2022-04-08	株洲千金药业股份有限公司	三萜类化合物和其药学上可接受的盐及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1593524A1 (de) *	1951-01-28	1970-08-13	Schering Ag	Verfahren zur Herstellung von 1,2alpha-Methylen-19-nor-steroiden
DE1087127B (de) *	1958-12-13	1960-08-18	Schering Ag	Verfahren zur Herstellung neuer progestativ wirksamer Ester von 2-Methyl-Steroiden
FR1405214A (fr) *	1962-06-21	1965-07-09	Rhone Poulenc Sa	Nouveaux stéroïdes de la série du prégnane et leur procédé de préparation
FR1525916A (fr) *	1965-11-09	1968-05-24	Schering Ag	Stéroïdes portant un groupe méthylène en position 1.2 et leur préparation
US3835160A (en) *	1967-06-06	1974-09-10	Schering Corp	3{40 -keto-2{40 ,3{40 -seco-1{40 -(2{40 )-yne steroidal derivatives, methods for their manufacture, and compounds produced thereby
US3891677A (en) *	1967-06-06	1975-06-24	Schering Corp	17{60 ,20,20,21-Bismethylenedioxy-4,5-seco-3-pregnyne-5-ones
BE757286A (fr) *	1969-10-10	1971-04-09	Ciba Geigy	Nouvelle 6alpha-methyl-19-nor progesterone et procede pour sa preparation
CH538462A (de) *	1970-10-07	1973-06-30	Ciba Geigy Ag	Ein neues Verfahren zur Herstellung von 6a-Methyl-19-nor-pregnenen
DE3402330A1 (de) *	1984-01-20	1985-07-25	Schering AG, 1000 Berlin und 4709 Bergkamen	1(alpha),2(alpha)-methylen-6-methylen- und 6(alpha)-methyl-pregnene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

1996
- 1996-01-22 EP EP96400146A patent/EP0785212A1/en not_active Withdrawn
1997
- 1997-01-17 EE EE9800219A patent/EE03692B1/xx not_active IP Right Cessation
- 1997-01-17 EP EP97902235A patent/EP0886645B1/en not_active Expired - Lifetime
- 1997-01-17 CA CA002243504A patent/CA2243504C/en not_active Expired - Fee Related
- 1997-01-17 DE DE69700470T patent/DE69700470T2/de not_active Expired - Lifetime
- 1997-01-17 TR TR1998/01399T patent/TR199801399T2/xx unknown
- 1997-01-17 HU HU9900684A patent/HU221796B1/hu not_active IP Right Cessation
- 1997-01-17 US US09/101,775 patent/US6180803B1/en not_active Expired - Fee Related
- 1997-01-17 PL PL97327998A patent/PL185608B1/pl not_active IP Right Cessation
- 1997-01-17 AP APAP/P/1998/001299A patent/AP1176A/en active
- 1997-01-17 CN CNB971918228A patent/CN1187366C/zh not_active Expired - Fee Related
- 1997-01-17 CZ CZ19982307A patent/CZ292047B6/cs not_active IP Right Cessation
- 1997-01-17 KR KR10-1998-0705607A patent/KR100396902B1/ko not_active IP Right Cessation
- 1997-01-17 BR BR9707064-5A patent/BR9707064A/pt not_active Application Discontinuation
- 1997-01-17 AT AT97902235T patent/ATE184015T1/de active
- 1997-01-17 ES ES97902235T patent/ES2140961T3/es not_active Expired - Lifetime
- 1997-01-17 SI SI9730015T patent/SI0886645T1/xx not_active IP Right Cessation
- 1997-01-17 NZ NZ330954A patent/NZ330954A/xx not_active IP Right Cessation
- 1997-01-17 WO PCT/EP1997/000357 patent/WO1997027210A1/en active IP Right Grant
- 1997-01-17 JP JP52656697A patent/JP4368945B2/ja not_active Expired - Fee Related
- 1997-01-17 RU RU98115774/04A patent/RU2166509C2/ru not_active IP Right Cessation
- 1997-01-17 IL IL12537997A patent/IL125379A/xx not_active IP Right Cessation
- 1997-01-18 TW TW086100511A patent/TW411345B/zh not_active IP Right Cessation
- 1997-01-21 CO CO97002478A patent/CO4810230A1/es unknown
- 1997-01-21 TN TNTNSN97015A patent/TNSN97015A1/fr unknown
- 1997-01-21 DZ DZ970014A patent/DZ2169A1/fr active
- 1997-01-21 MY MYPI97000215A patent/MY116845A/en unknown
- 1997-01-21 JO JO19971971A patent/JO1971B1/en active
- 1997-01-21 AR ARP970100228A patent/AR005500A1/es active IP Right Grant
- 1997-01-22 ZA ZA9700521A patent/ZA97521B/xx unknown
- 1997-01-22 PE PE1997000035A patent/PE55998A1/es not_active Application Discontinuation
- 1997-01-22 ID IDP970175A patent/ID15840A/id unknown
1998
- 1998-07-21 IS IS4800A patent/IS1902B/is unknown
- 1998-07-21 NO NO983356A patent/NO309572B1/no not_active IP Right Cessation
- 1998-07-22 OA OA9800117A patent/OA10813A/en unknown
1999
- 1999-07-29 HK HK99103263A patent/HK1018216A1/xx not_active IP Right Cessation
- 1999-11-25 GR GR990403047T patent/GR3031954T3/el unknown
2009
- 2009-02-04 JP JP2009024075A patent/JP2009167188A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
HUP9900684A3 (en)	1999-11-29
ZA97521B (en)	1997-08-04
GR3031954T3 (en)	2000-03-31
OA10813A (en)	2003-01-28
KR100396902B1 (ko)	2004-05-03
PE55998A1 (es)	1998-10-01
CO4810230A1 (es)	1999-06-30
PL327998A1 (en)	1999-01-04
DE69700470T2 (de)	2000-03-30
CZ292047B6 (cs)	2003-07-16
ATE184015T1 (de)	1999-09-15
ES2140961T3 (es)	2000-03-01
TW411345B (en)	2000-11-11
JP4368945B2 (ja)	2009-11-18
NO983356L (no)	1998-07-21
IL125379A0 (en)	1999-03-12
AU708135B2 (en)	1999-07-29
CZ230798A3 (cs)	1998-11-11
CN1209811A (zh)	1999-03-03
PL185608B1 (pl)	2003-06-30
AU1595597A (en)	1997-08-20
NZ330954A (en)	1998-10-28
AP9801299A0 (en)	1998-09-30
EE03692B1 (et)	2002-04-15
IS1902B (is)	2003-11-20
CN1187366C (zh)	2005-02-02
EP0785212A1 (en)	1997-07-23
HUP9900684A2 (hu)	1999-07-28
CA2243504A1 (en)	1997-07-31
MY116845A (en)	2004-04-30
CA2243504C (en)	2004-03-30
SI0886645T1 (en)	1999-12-31
DZ2169A1 (fr)	2002-12-25
AP1176A (en)	2003-06-30
RU2166509C2 (ru)	2001-05-10
HK1018216A1 (en)	1999-12-17
EP0886645A1 (en)	1998-12-30
HU221796B1 (hu)	2003-01-28
WO1997027210A1 (en)	1997-07-31
BR9707064A (pt)	1999-12-28
TR199801399T2 (xx)	1998-10-21
IS4800A (is)	1998-07-21
US6180803B1 (en)	2001-01-30
ID15840A (id)	1997-08-14
TNSN97015A1 (fr)	2005-03-15
EE9800219A (xx)	1998-12-15
AR005500A1 (es)	1999-06-23
EP0886645B1 (en)	1999-09-01
JP2009167188A (ja)	2009-07-30
JP2000503980A (ja)	2000-04-04
JO1971B1 (en)	1997-12-15
NO309572B1 (no)	2001-02-19
DE69700470D1 (de)	1999-10-07
KR19990081895A (ko)	1999-11-15
IL125379A (en)	2003-05-29

Publication	Publication Date	Title
NO983356D0 (no)	1998-07-21	Nye 19-nor-pregnenderivater
NO992400D0 (no)	1999-05-19	Nye substituerte pyrazolderivater
DE69735712D1 (de)	2006-05-24	Aryl-pyrimidin-derivate
DK0891332T3 (da)	2004-07-05	6-phenylpyridyl-2-aminderivater
NO970512D0 (no)	1997-02-05	Nye heteroaryl-oksazolidinoner
NO970374L (no)	1997-02-19	Nye forbindelser
NO20001938D0 (no)	2000-04-13	Nye aryloksy-alkyl-dialkylaminer
NO981946D0 (no)	1998-04-29	Imidazoquinazolin-derivater
DE69732576D1 (de)	2005-03-31	Tetrahydrobenzindolon-derivate
DK0906288T3 (da)	2003-01-06	Nye forbindelser
NO960268D0 (no)	1996-01-23	Nye dialkoksypyridinylbenzimidazolderivater
IS5026A (is)	1999-04-15	2-metoxýfenýlpíperasín afleiður
DK0931087T3 (da)	2002-07-01	Nye pyranosidderivater
BR9507892A (pt)	1997-11-18	Novos derivados de diamino-metilideno
DK0846683T3 (da)	2001-11-05	4-hydroxypiperidinderivater
NO990072D0 (no)	1999-01-08	Nye forbindelser
NO991096D0 (no)	1999-03-05	Nye fremgangsmÕter
DK0946548T3 (da)	2002-06-24	Nye heterocykliske substituerede pyrrolidinamidderivater
NO992302D0 (no)	1999-05-12	Piperidin-derivater
BR9509877A (pt)	1997-09-30	Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
FI965181L (fi)	1998-06-21	Polyalkoholi-peptidijohdannaiset
NO993171D0 (no)	1999-06-25	Substituerte propionylderivater
BR9708310A (pt)	1999-08-03	Derivados de 2-tioxotetrahidropirimidin-4-ona
NO983505D0 (no)	1998-07-30	Nye fenantrider
DK0886645T3 (da)	2000-03-06	Nye 19-nor-pregnen-derivater

Legal Events

Date	Code	Title	Description
2012-08-27	MM1K	Lapsed by not paying the annual fees